Current reports
6-K
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
20 Nov 23
6-K
Legend Biotech Corp. 6-K
13 Nov 23
6-K
Legend Biotech Corporation 6-K
17 Oct 23
6-K
Voting Results of 2023 Annual General Meeting
25 Sep 23
6-K
Legend Biotech Corporation 6-K
28 Aug 23
6-K
Current report (foreign)
21 Aug 23
6-K
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
15 Aug 23
6-K
Legend Biotech Corporation 6-K
20 Jul 23
6-K
Legend Biotech Corporation 6-K
6 Jun 23
6-K
Legend Biotech 6-K
5 Jun 23
Registration and prospectus
F-3ASR
Automatic shelf registration (foreign)
26 May 23
424B5
Prospectus supplement for primary offering
8 May 23
D
$200.00 mm in equity, sold $200.00 mm, 1 investor
28 Apr 23
424B5
Prospectus supplement for primary offering
27 Jul 22
424B5
Prospectus supplement for primary offering
25 Jul 22
424B5
Prospectus supplement for primary offering
17 Dec 21
FWP
Free writing prospectus
16 Dec 21
424B5
Prospectus supplement for primary offering
14 Dec 21
424B3
Prospectus supplement
14 Jul 21
F-3
Shelf registration (foreign)
2 Jul 21
Proxies
No filings
Other
UPLOAD
Letter from SEC
15 Sep 23
CORRESP
Correspondence with SEC
8 Sep 23
UPLOAD
Letter from SEC
31 Aug 23
UPLOAD
Letter from SEC
27 Feb 23
CORRESP
Correspondence with SEC
11 Oct 22
UPLOAD
Letter from SEC
6 Oct 22
CORRESP
Correspondence with SEC
30 Sep 22
UPLOAD
Letter from SEC
2 Sep 22
EFFECT
Notice of effectiveness
14 Jul 21
CORRESP
Correspondence with SEC
9 Jul 21
Ownership
144/A
Notice of proposed sale of securities (amended)
17 Oct 23
144
Notice of proposed sale of securities
17 Oct 23
144
Notice of proposed sale of securities
16 Oct 23
144
Notice of proposed sale of securities
27 Sep 23
144
Notice of proposed sale of securities
22 Sep 23
144
Notice of proposed sale of securities
22 Sep 23
144
Notice of proposed sale of securities
18 Sep 23
144
Notice of proposed sale of securities
23 Aug 23
144
Notice of proposed sale of securities
26 Jun 23
144
Notice of proposed sale of securities
22 Jun 23